Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Gadopentetate Dimeglumine Injectable Solution bulk supplier for pharma manufacturers

Gadopentetate Dimeglumine Injectable Solution 0.5 mol/L Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 0.5 mol/L

Reference Brands: Magnevist(US & EU)

Category: Contrast Agent

Gadopentetate dimeglumine is a gadolinium-based contrast agent that enhances MRI images by increasing tissue and vascular radiopacity. It provides detailed visualization of blood vessels, organs, and abnormalities, supporting accurate diagnosis. Benefits include high image quality, rapid excretion, safety, and improved detection of neurological, cardiovascular, and musculoskeletal conditions worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Gadopentetate dimeglumine, marketed as Magnevist, is approved in the US by the FDA and in the EU via EMA for MRI imaging of blood vessels, organs, and tissues. Regulatory approval requires comprehensive dossiers, including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional compliance with safety and manufacturing standards. For dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe administration, and global availability, enabling high-quality diagnostic imaging in neurology, cardiology, and musculoskeletal assessments worldwide.

Gadopentetate Dimeglumine Injectable Solution — third party manufacturing & bulk supply

Gadopentetate Dimeglumine Injectable Solution 0.5 mol/L is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Gadopentetate Dimeglumine Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Gadopentetate Dimeglumine Injectable Sol... →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Gadopentetate Dimeglumine Injectable is a gadolinium‑based contrast agent used in magnetic resonance imaging (MRI) to enhance the visibility of blood vessels, organs, and tissues during diagnostic imaging procedures. It improves image contrast, especially in detecting abnormalities with altered vascularity.

It is used as a diagnostic tool during MRI scans to help visualize central nervous system lesions, vascular structures, and other abnormalities in soft tissues by increasing contrast on the MRI images.

The generic name is Gadopentetate Dimeglumine.

A well-known trade name for Gadopentetate Dimeglumine Injectable is Magnevist. Other regional brand variants include Magnevita, Viewgam, EMARAY, Gadoimage, and Magnilek, depending on the country and manufacturer.

It is administered intravenously as an injection by a trained healthcare professional during an MRI procedure.

The original innovator brand Magnevist was introduced by Schering AG (now part of Bayer). Multiple pharmaceutical companies produce generic or licensed versions in different global markets.

It is manufactured by various pharmaceutical companies in regions such as the United States, Europe, and Asia. Specific manufacturing locations vary by company and product registration.

Related Products

Gadobenate Dimeglumine

Strength:
529 mg/mL

Form: Injection

Reference Brands: MultiHance (USA)

View Details
Ethiodized Oil

Strength:
480 mg

Form: Injection

Reference Brands: Lipiodol (USA/EU)

View Details
Gadopiclenol

Strength:
0.25 mmol/mL

Form: Injection

Reference Brands: Elucirem (USA), Vueway(EU)

View Details
Perflutren

Strength:
0.19 mg/ ml

Form: Injection

Reference Brands: Definity (USA), Optison (USA), Luminity (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.